The summaries of product characteristics (SPC) contain the information relevant to the use of the medicinal products and of importance to health care professionals. The SPCs are published in Finnish; the use of Finnish key words in the search fields is therefore recommended.
Some of the medicinal products contain a condition relevant to the prescribing of the product and not always found in the SPC. The conditions for prescribing and the products covered by this condition are found in the FimeaWeb search.
The SPCs processed as part of the EU centralised marketing authorisation procedure are published by the European Medicines Agency, EMA. Fimea's service contains links to the documents on medicinal products (EPAR PI) on the EMA website. Drugs belonging to the centralised authorisation procedure can be searched in Fimea's service by using an alphabetical list or by entering the product name or ATC code.
The material being published is not necessarily complete or up-to-date due to the technical quality of files submitted to the Finnish Medicines Agency Fimea or earlier to the National Agency for Medicines and the delays in delivery. For this reason, Fimea cannot guarantee that the document on the Internet fully complies with the summary of product characteristics and package leaflet officially approved by a desicion for a marketing authorisation. Only the hard copies of the SPCs and the PLs, which are in accordance with the marketing authorisation, are conclusive.
Summaries of Product Characteristics 61 - 90 of 254 |
|
|
Package leaflet | Status for supply | Name of the medicinal product |
PL
|
Resepti
|
Remodulin 2.5 mg-ml infuusioneste, liuos SPC 2022-03-21
|
PL
|
Resepti
|
Remodulin 5 mg-ml infuusioneste, liuos SPC 2022-03-21
|
|
|
European Medicines Agency's website: Remsima - EMA: EPAR PI
Finnish Swedish
|
|
|
European Medicines Agency's website: Renagel - EMA: EPAR PI
Finnish Swedish
|
PL
|
Resepti
|
Renitec 5 mg, 10 mg, 20 mg tabletti SPC 2023-06-05
|
PL
|
Resepti
|
Renitec comp tabletti SPC 2022-04-22
|
PL
|
Itsehoito
|
Rennie Comp purutabletti SPC 2024-09-25
|
PL
|
Itsehoito
|
Rennie Lakritsi imeskelytabletti SPC 2022-10-06
|
PL
|
Itsehoito
|
Rennie Orange imeskelytabletti SPC 2022-02-03
|
PL
|
Itsehoito
|
Rennie Peppermint imeskelytabletti SPC 2022-02-03
|
PL
|
Itsehoito
|
Rennie Spearmint imeskelytabletti SPC 2022-02-03
|
PL
|
Resepti
|
Renocis 1 mg valmisteyhdistelmä radioaktiivista lääkettä varten SPC 2023-11-23.docx
|
|
|
European Medicines Agency's website: Renvela - EMA: EPAR PI
Finnish Swedish
|
PL
|
Resepti
|
Repaglinid Stada 0,5 mg, 1 mg, 2 mg tabletti SPC 2021-05-27
|
|
|
European Medicines Agency's website: Repaglinide Accord - EMA: EPAR PI
Finnish Swedish
|
|
|
European Medicines Agency's website: Repaglinide Krka - EMA: EPAR PI
Finnish Swedish
|
|
|
European Medicines Agency's website: Repaglinide Teva - EMA: EPAR PI
Finnish Swedish
|
|
|
European Medicines Agency's website: Repatha - EMA: EPAR PI
Finnish Swedish
|
PL
|
Resepti
|
Repevax injektioneste, suspensio, esitäytetty ruisku SPC
|
|
|
European Medicines Agency's website: Replagal - EMA: EPAR PI
Finnish Swedish
|
PL
|
Resepti
|
Requip Depot 2 mg, 4 mg, 8 mg depottabletti SPC 2023-08-18
|
PL
|
Resepti
|
RescueFlow infuusioneste, liuos SPC 2024-04-24
|
PL
|
Itsehoito
|
Resilar 3 mg-ml oraaliliuos SPC 2022-04-12
|
|
|
European Medicines Agency's website: Resolor - EMA: EPAR PI
Finnish Swedish
|
PL
|
Resepti
|
Resonium jauhe oraalisuspensiota_peräruiskesuspensiota varten SPC 2023-08-29
|
|
|
European Medicines Agency's website: Respreeza - EMA: EPAR PI
Finnish Swedish
|
|
|
European Medicines Agency's website: Retacrit - EMA: EPAR PI
Finnish Swedish
|
PL
|
Itsehoito
|
Retafer 50 mg, 100 mg depottabletti SPC 2021-10-07
|
PL
|
Resepti
|
Retafyllin 200 mg depottabletti, 300 mg depottabletti SPC 2022-01-31
|
PL
|
Resepti
|
Retrovir 250 mg kapseli, kova SPC 2022-08-19
|
|